Respirology

Previous issue Volume 22 Issue 8
November 2017
Next issue
Index Submit
an article
About
Respirology
Read this
issue's articles
EDITORIALS
1481Managing patients with interstitial lung disease: Two more pieces of the puzzle
Francesco Macagno, Paolo Maria Leone & Luca Richeldi
10.1111/resp.13195
1483Simulation and assessment tools in EBUS TBNA training: What are we waiting for?
David Fielding
10.1111/resp.13136
1485Phenotyping asthma: More complex than just age
Rodrigo Athanazio & Alberto Cukier
10.1111/resp.13120
1487Asthma prescribing: Where are we headed?
Richard Beasley, Jo Hardy & Robert Hancox
10.1111/resp.13159
1489Hypersensitivity pneumonitis: A protean and challenging disease
Adelle S Jee, Helen E Jo & Tamera J Corte
10.1111/resp.13158
1491Cough in fibrotic lung disease: An unresolved challenge
Peter Saunders & Toby M Maher
10.1111/resp.13116
1493Multiple sub-solid nodules: Different or just more?
Alistair R Miller
10.1111/resp.13110
1495Broader implications for the widened pulmonary artery?
Martin I MacDonald
10.1111/resp.13119
1497Home mechanical ventilation for stable COPD in GOLD 2017: What are we ventilating?
Jose L Lopez-Campos, Candelaria Caballero-Eraso & Emilia Barrot-Cortés
10.1111/resp.13091
INVITED REVIEW SERIES
Respiratory Sleep Disorders
1500Treating OSA: Current and emerging therapies beyond CPAP
Geraldo Lorenzi-Filho, Fernanda R Almeida & Patrick J Strollo
10.1111/resp.13144
1508Does remote monitoring change OSA management and CPAP adherence?
Jean L Pépin, Renaud Tamisier, Dennis Hwang, Suresh Mereddy & Sairam Parthasarathy
10.1111/resp.13183
Respiratory Infections in the Asia-Pacific Region
1518The global burden of respiratory infections in indigenous children and adults: A review
Thilini L Basnayake, Lucy C Morgan & Anne B Chang
10.1111/resp.13131
1529Community-acquired pneumonia management and outcomes in the era of health information technology
Ian D Mecham, Caroline Vines & Nathan C Dean
10.1111/resp.13132
1536Regional differences in antibiotic-resistant pathogens in patients with pneumonia: Implications for clinicians
Yuichiro Shindo & Yoshinori Hasegawa
10.1111/resp.13135
SYSTEMATIC REVIEW
1547Training and proficiency in endobronchial ultrasound-guided transbronchial needle aspiration: A systematic review
Inderpaul S Sehgal, Sahajal Dhooria, Ashutosh N Aggarwal & Ritesh Agarwal
10.1111/resp.13121
ORIGINAL ARTICLES
Asthma and Allergy
1558Age is associated with asthma phenotypes
Eduardo V Ponte, Aline Lima, Paula C A Almeida, Juliana P V de Jesus, Valmar B Lima, Nicola Scichilone, Adelmir Souza-Machado & Álvaro A Cruz
10.1111/resp.13102

In this cross-sectional study, we demonstrated that asthmatic subjects aged 65 years or older have lower odds of atopic and eosinophilic phenotypes compared with younger subjects, whereas they present with higher odds of irreversible airway obstruction and severe asthma.

1564Treatment evaluation using lung sound analysis in asthmatic children
Chizu Habukawa, Katsumi Murakami, Mitsuru Endoh, Noriaki Horii & Yukio Nagasaka
10.1111/resp.13109

We developed a new technology for analysing lung sounds using the ic700 (index of the chest wall at 700 Hz, sound intensity at 700 Hz). We assess the effects of inhaled corticosteroid (ICS) in childhood and infantile asthma in a non-invasive manner and predict an attack while avoiding the influence of individual differences of airflow.

1570Is higher population-level use of ICS/LABA combination associated with better asthma outcomes? Cross-sectional surveys of nationally representative populations in New Zealand and Australia
Helen K Reddel, Lutz Beckert, Angela Moran, Tristram Ingham, Rosario D Ampon, Matthew J Peters & Susan M Sawyer
10.1111/resp.13123

Poor asthma symptom control and urgent healthcare episodes remain common in New Zealand (NZ) and Australia (AU). More costly inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA) use was strikingly higher in AU, but NZ achieved similar outcomes with wider use of cheaper ICS monotherapy and better adherence. Pharmaceutical regulation, patient costs and patterns of clinical practice are likely influences.

COPD
1579Continuous non-invasive PCO2 monitoring in weaning patients: Transcutaneous is advantageous over end-tidal PCO2
Sarah B Schwarz, Wolfram Windisch, Friederike S Magnet, Claudia Schmoor, Christian Karagiannidis, Jens Callegari, Sophie E Huttmann & Jan H Storre
10.1111/resp.13095

The present trial was designed to investigate the potential roles of end-tidal partial pressure of carbon dioxide (PetCO2) and transcutaneous partial pressure of carbon dioxide (PtcCO2) monitoring in patients with prolonged weaning, especially in COPD patients. The present study showed that PtcCO2 monitoring reflects the gold standard method of arterial partial pressure of carbon dioxide (PaCO2) measurements within predefined clinically acceptable range, while PetCO2 showed a systematic underestimation of PaCO2.

Environmental and Occupational Lung Disease
1585Evaluation of visual and computer-based CT analysis for the identification of functional patterns of obstruction and restriction in hypersensitivity pneumonitis
Joseph Jacob, Brian J Bartholmai, Anne Laure Brun, Ryoko Egashira, Srinivasan Rajagopalan, Ronald Karwoski, Vasileios Kouranos, Maria Kokosi, David M Hansell & Athol U Wells
10.1111/resp.13122

In hypersensitivity pneumonitis, computer-derived (CALIPER) variables are stronger predictors of restriction and obstruction than visual computed tomography (CT) scores as judged by correlations between morphology and functional indices. The pulmonary vessel volume demonstrated the strongest correlations of all CT variables with restrictive indices and may represent a new measure of interstitial damage.

Interstitial Lung Disease
1592Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases
Jasmine Z Cheng, Pearce G Wilcox, Ian Glaspole, Tamera J Corte, Darra Murphy, Cameron J Hague & Christopher J Ryerson
10.1111/resp.13084

Cough is more common, more severe and more often productive in idiopathic pulmonary fibrosis (IPF) and chronic hypersensitivity pneumonitis (HP) compared to systemic sclerosis-associated interstitial lung disease (SSc-ILD), despite similar ILD severity. Cough severity is independently associated with dyspnoea, is not associated with other common causes of cough in ILD and is an independent predictor of quality of life.

1598Portable oxygen concentrators versus oxygen cylinder during walking in interstitial lung disease: A randomized crossover trial
Yet H Khor, Christine F McDonald, Anita Hazard, Karen Symons, Glen Westall, Ian Glaspole, Nicole S L Goh & Anne E Holland
10.1111/resp.13083

This is the first crossover trial comparing the clinical performance characteristics of two portable oxygen concentrators (the Inogen One G2 and the EverGo) with that of a compressed oxygen cylinder in patients with interstitial lung disease (ILD), showing comparable performance among the three devices.

1604Resolution rate of pulmonary sarcoidosis and its related factors in a Japanese population
Takeshi Hattori, Satoshi Konno, Noriharu Shijubo, Mitsuhide Ohmichi, Tetsuo Yamaguchi & Masaharu Nishimura
10.1111/resp.13105

This study suggests that the overall rate of resolution of pulmonary sarcoidosis is lower than that reported in some previous studies that were conducted several decades ago in Japan. This may be, at least in part, due to the ageing of the Japanese population.

1609Disease severity staging system for idiopathic pulmonary fibrosis in Japan
Yasuhiro Kondoh, Hiroyuki Taniguchi, Kensuke Kataoka, Taiki Furukawa, Masahiko Ando, Kenta Murotani, Michiaki Mishima, Yoshikazu Inoue, Takashi Ogura, Masashi Bando, Koichi Hagiwara, Takafumi Suda, Hirofumi Chiba, Hiroki Takahashi, Yukihiko Sugiyama & Sakae Homma
10.1111/resp.13138

We propose a revised disease severity staging system for idiopathic pulmonary fibrosis (IPF) in Japan, consisting of arterial partial pressure of oxygen (PaO2) and exercise desaturation, and investigate its usefulness as a predictor of mortality. We show that this revised J-system can be a valuable tool for prognostication and clinical management for IPF.

Lung Cancer
1615
Natural history and clinical characteristics of multiple pulmonary nodules with ground glass opacity
Yuki Sato, Daichi Fujimoto, Takeshi Morimoto, Keiichiro Uehara, Kazuma Nagata, Ichiro Sakanoue, Hiroshi Hamakawa, Yutaka Takahashi, Yukihiro Imai & Keisuke Tomii
10.1111/resp.13089

We describe the natural history of patients with multiple ground glass nodules (GGNs). In most GGNs, growth occurs within the first 36 months. Residual GGN growth after initial growth was common in multiple-GGN patients. A past history of lung cancer and size >10 mm are risk factors for growth.

Lung Function
1622Reference data for BabyBody-plethysmographic measurements in Chinese neonates and infants
Gaoli Jiang, Albert Li, Libo Wang, Liling Qian, Yun Cao, Jianfeng Huang, Chengzhou Wan & Xiaobo Zhang
10.1111/resp.13104

This is the first description of pulmonary function in healthy Chinese neonates and infants. Pulmonary function in Chinese differs to those of European descent and therefore population-appropriate reference data are important.

1630Spirometry reference values for population aged 7–80 years in China
Jingzhou Zhang, Xiao Hu & Guangliang Shan
10.1111/resp.13118

Benefitting from a nationwide health survey and a suitable statistical modelling technique, spirometry reference values covering all ages of the general population in China were developed, addressing a long-standing need for this data. Moreover, previous spirometry predictive equations showed unfavourable generalizability when applied to this study population.

1637Small airway dysfunction in chronic hypersensitivity pneumonitis
Selene Guerrero Zúñiga, Julia Sánchez Hernández, Heidegger Mateos Toledo, Mayra Mejía Ávila, Laura Gochicoa-Rangel, José Luis Miguel Reyes, Moisés Selman & Luis Torre-Bouscoulet
10.1111/resp.13124

Small airway involvement in patients with chronic hypersensitivity pneumonitis has been well characterized pathologically. Our study suggests, for the first time, that phase 3 slope by ultrasonic pneumography may be helpful in the medical care of these patients due to improvement with treatment and negative correlation with forced vital capacity (FVC).

Paediatric Lung Disease
1643Physical activity and asthma control level in children and adolescents
Natasha Y Matsunaga, Marina S Oliveira, André M Morcillo, José D Ribeiro, Maria A G O Ribeiro & Adyléia A D C Toro
10.1111/resp.13093

Most asthmatic patients are physically active. Although exercise is known to improve health, the effect of physical activity on asthma control has not been studied. Our study showed no association between physical activity and asthma control, spirometric measurements and quality of life in children and adolescents with asthma.

Pulmonary Vascular Disease
1649Changes in main pulmonary artery diameter during follow-up have prognostic implications in pulmonary arterial hypertension
Adriano R Tonelli, Scott Johnson, Laith Alkukhun, Ruchi Yadav & Raed A Dweik
10.1111/resp.13073

It remains unclear whether the increase in main pulmonary artery (PA) diameter over time has prognostic implications in patients with pulmonary arterial hypertension. In the present study, we found that an increase in main PA diameter was associated with higher PA pressures, lower PA compliance, worse right ventricular function and reduced survival.

Respiratory Infections
1656Anaerobic antibiotic usage for pneumonia in the medical intensive care unit
Mutsumi J Kioka, Bruno DiGiovine, Mohamed Rezik & Jeffrey H Jennings
10.1111/resp.13111

For patients with pneumonia, current guidelines recommend narrow criteria as justification for prescribing anaerobic antibiotics. We found a significant proportion of patients with pneumonia who received anaerobic antibiotics without clear indications, and that there was an increased intensive care unit (ICU) length of stay associated with such use.

Sleep and Ventilation
1662
Dynamic loop gain increases upon adopting the supine body position during sleep in patients with obstructive sleep apnoea
Simon A Joosten, Shane A Landry, Scott A Sands, Philip I Terrill, Dwayne Mann, Christopher Andara, Elizabeth Skuza, Anthony Turton, Philip Berger, Garun S Hamilton & Bradley A Edwards
10.1111/resp.13108

We explored whether increased ventilatory control instability (i.e. loop gain) is responsible for the observed increase in respiratory event frequency in the supine sleeping position in obstructive sleep apnoea patients. Loop gain is significantly increased in the supine compared with lateral sleeping position, although the magnitude of change is small.

Tuberculosis
1670Tuberculosis increases the risk of peripheral arterial disease: A nationwide population-based study
Sheng-Huei Wang, Wu-Chien Chien, Chi-Hsiang Chung, Fu-Huang Lin, Chung-Kan Peng, Chih-Feng Chian & Chih-Hao Shen
10.1111/resp.13117

This study showed that patients with tuberculosis (TB) have a significantly higher risk of developing peripheral arterial disease (PAD) than healthy control subjects. TB should be considered when evaluating a patient's risk of developing PAD.

CORRESPONDENCE
1677False-positive breathalyser tests and use of metered-dose inhalers: Does inhalation technique affect test results?
Timothy H Self, Paul J Jones & Christopher W Sands
10.1111/resp.13113

Index

2024 MayVol. 29 Issue 5
2024 AprVol. 29 Issue 4
2024 MarVol. 29 Issue 3
2023 MarVol. 29 Supplement 1
ANZSRS/TSANZ Annual Scientific Meeting 2024
2024 FebVol. 29 Issue 2
2024 JanVol. 29 Issue 1
2023 DecVol. 28 Issue 12
2023 NovVol. 28 Issue 11
2023 NovVol. 28 Supplement 4
APSR 2023 Congress Abstracts
2023 OctVol. 28 Issue 10
2023 SepVol. 28 Issue 9
2023 AugVol. 28 Issue 8
2023 JulVol. 28 Issue 7
2023 JunVol. 28 Issue 6
2023 MayVol. 28 Issue 5
2023 AprVol. 28 Issue 4
2023 MarVol. 28 Issue 3
2023 MarVol. 28 Supplement 3
Australian Lung Cancer Conference 2023
2023 MarVol. 28 Supplement 2
ANZSRS/TSANZ Annual Scientific Meeting 2023
2023 FebVol. 28 Issue 2
2023 FebVol. 28 Supplement 1
APSR 2022 Congress Abstracts
2023 JanVol. 28 Issue 1
2022 DecVol. 27 Issue 12
2022 NovVol. 27 Issue 11
2022 OctVol. 27 Issue 10
2022 SepWorld Lung Day 2022
2022 SepVol. 27 Issue 9
2022 AugVol. 27 Issue 8
2022 JulVol. 27 Issue 7
2022 JunVol. 27 Issue 6
Special Issue: Occupational Lung Health
2022 MayVol. 27 Issue 5
2022 AprVol. 27 Issue 4
2022 MarVol. 27 Issue 3
2022 MarVol. 27 Issue s1
ANZSRS and TSANZ abstracts
2022 FebVol. 27 Issue 2
2022 JanVol. 27 Issue 1
2021 DecVol. 26 Issue 12
2021 NovVol. 26 Issue 11
2021 NovVol. 26 Supplement 3
APSR Congress Abstracts
2021 OctVol. 26 Issue 10
2021 SepVol. 26 Issue 9
2021 AugVol. 26 Issue 8
2021 JulVol. 26 Issue 7
2021 JunVol. 26 Issue 6
2021 MayVol. 26 Issue 5
2021 AprVol. 26 Issue 4
2021 AprVol. 26 Issue s2
ANZSRS and TSANZ abstracts
2021 MarVol. 26 Issue 3
2021 FebVol. 26 Issue 2
2021 JanVol. 26 Issue s1
Supplement: APSR Assembly Virtual Meetings
2021 JanVol. 26 Issue 1
2020 DecVol. 25 Issue 12
2020 NovVol. 25 Issue 11
2020 NovVol. 25 Issue s2
Essential update in lung cancer medicine
2020 OctVol. 25 Issue 10
2020 SepVol. 25 Issue 9
Special issue: Interventional Pulmonoogy pearls
2020 AugVol. 25 Issue 8
2020 JulVol. 25 Issue 7
2020 JunVol. 25 Issue 6
2020 JunVol. 25 Supplement 1
ANZSRS and TSANZ abstracts
2020 MayVol. 25 Issue 5
2020 AprVol. 25 Issue 4
2020 MarVol. 25 Issue 3
2020 FebVol. 25 Issue 2
2020 JanVol. 25 Issue 1
2019 DecVol. 24 Issue 12
2019 NovVol. 24 Issue 11
2019 NovVol. 24 Supplement 2
APSR Congress Abstracts
2019 OctVol. 24 Issue 10
2019 SepVol. 24 Issue 9
2019 AugVol. 24 Issue 8
2019 JulVol. 24 Issue 7
2019 JunVol. 24 Issue 6
2019 MayVol. 24 Issue 5
2019 AprVol. 24 Issue 4
2019 MarVol. 24 Issue 3
2019 MarVol. 24 Supplement 1
ANZSRS and TSANZ abstracts
2019 FebVol. 24 Issue 2
2019 JanVol. 24 Issue 1
2018 DecVol. 23 Issue 12
2018 NovVol. 23 Supplement 2
APSR Congress Abstracts
2018 NovVol. 23 Issue 11
2018 OctVol. 23 Issue 10
2018 SepVol. 23 Issue 9
2018 AugVol. 23 Issue 8
2018 JulVol. 23 Issue 7
2018 JunVol. 23 Issue 6
2018 MayVol. 23 Issue 5
2018 AprVol. 23 Issue 4
2018 MarVol. 23 Supplement 1
ANZSRS and TSANZ abstracts
2018 MarVol. 23 Issue 3
2018 FebVol. 23 Issue 2
2018 JanVol. 23 Issue 1
2017 NovVol. 22 Supplement 3
APSR Congress Abstracts
2017 NovVol. 22 Issue 8
2017 OctVol. 22 Issue 7
2017 AugVol. 22 Issue 6
2017 JulyVol. 22 Issue 5
2017 MayVol. 22 Issue 4
2017 AprVol. 22 Issue 3
2017 MarVol. 22 Supplement 2
ANZSRS and TSANZ abstracts
2017 MarVol. 22 Supplement 1
Airway Vista abstracts
2017 FebVol. 22 Issue 2
2017 JanVol. 22 Issue 1
2016 NovVol. 21 Supplement 3
APSR Congress Abstracts
2016 NovVol. 21 Issue 8
2016 OctVol. 21 Issue 7
2016 AugVol. 21 Issue 6
2016 JulVol. 21 Issue 5
2016 MayVol. 21 Issue 4
2016 AprVol. 21 Supplement 2
ANZSRS and TSANZ abstracts
2016 AprVol. 21 Issue 3
2016 MarVol. 21 Supplement 1
Airway Vista abstracts
2016 FebVol. 21 Issue 2
2016 JanVol. 21 Issue 1
2015 DecVol. 20 Supplement 3
APSR Congress Abstracts
2015 NovVol. 20 Issue 8
2015 OctVol. 20 Issue 7
2015 AugVol. 20 Issue 6
2015 JulVol. 20 Issue 5
2015 MayVol. 20 Issue 4
2015 AprVol. 20 Issue 3
2015 MarVol. 20 Supplement 2
ANZSRS and TSANZ abstracts
2015 MarVol. 20 Supplement 1
Airway Vista abstracts
2015 FebVol. 20 Issue 2
2015 JanVol. 20 Issue 1
2014 NovVol. 19 Issue 8
2014 NovVol. 19 Supplement 3
APSR Congress Abstracts
2014 OctVol. 19 Issue 7
2014 AugVol. 19 Issue 6
2014 JulVol. 19 Issue 5
2014 MayVol. 19 Issue 4
2014 AprVol. 19 Issue 3
2014 AprVol. 19 Supplement 2
ANZSRS and TSANZ abstracts
2014 MarVol. 19 Supplement 1
Airway Inflammation
2014 FebVol. 19 Issue 2
2014 JanVol. 19 Issue 1
2013 NovVol. 18 Issue 8
2013 OctVol. 18 Supplement 4
APSR Congress Abstracts
2013 NovVol. 18 Supplement 3
Airway Inflammation
2013 OctVol. 18 Issue 7
2013 AugVol. 18 Issue 6
2013 JulVol. 18 Issue 5
2013 MayVol. 18 Issue 4
2013 AprVol. 18 Issue 3
2013 AprVol. 18 Supplement 2
ANZSRS and TSANZ abstracts
2013 AprVol. 18 Supplement 1
Airway Vista abstracts
2013 FebVol. 18 Issue 2
2013 JanVol. 18 Issue 1
2012 DecVol. 17 Supplement 2
APSR Congress Abstracts
2012 NovVol. 17 Issue 8
2012 OctVol. 17 Issue 7
2012 AugVol. 17 Issue 6
2012 JulVol. 17 Issue 5
2012 MayVol. 17 Issue 4
2012 AprVol. 17 Issue 3
2012 AprVol. 17 Supplement 1
ANZSRS and TSANZ abstracts
2012 FebVol. 17 Issue 2
2012 JanVol. 17 Issue 1
2011 NovVol. 16 Issue 8
2011 NovVol. 16 Supplement 2
APSR Congress Abstracts
2011 OctVol. 16 Issue 7
2011 AugVol. 16 Issue 6
2011 JulVol. 16 Issue 5
2011 MayVol. 16 Issue 4
2011 AprVol. 16 Issue 3
2011 AprVol. 16 Supplement 1
ANZSRS and TSANZ abstracts
2011 FebVol. 16 Issue 2
2011 JanVol. 16 Issue 1
2010 NovVol. 15 Supplement 2
APSR Congress Abstracts
2010 NovVol. 15 Issue 8
2010 OctVol. 15 Issue 7
2010 AugVol. 15 Issue 6
2010 JulVol. 15 Issue 5
2010 MayVol. 15 Issue 4
2010 AprVol. 15 Issue 3
2010 MarVol. 15 Supplement 1
ANZSRS and TSANZ abstracts
2010 FebVol. 15 Issue 2
2010 JanVol. 15 Issue 1
2009 NovVol. 14 Issue 8
2009 NovVol. 14 Supplement 3
APSR Congress Abstracts
2009 OctVol. 14 Supplement 2
Guidelines: Hospital-Acquired Pneumonia
2009 SepVol. 14 Issue 7
2009 Vol. 14 Issue 6
2009 JulVol. 14 Issue 5
2009 MayVol. 14 Issue 4
2009 AprVol. 14 Issue 3
2009 AprVol. 14 Supplement 1
ANZSRS and TSANZ abstracts
2009 MarVol. 14 Issue 2
2009 JanVol. 14 Issue 1
2008 NovVol. 13 Issue 7
2008 NovVol. 13 Supplement 5
APSR Congress Abstracts
2008 NovVol. 13 Supplement 4
Lung Disease
2008 SepVol. 13 Issue 6
2008 SepVol. 13 Supplement 3
ESAP: TB
2008 JulVol. 13 Issue 5
2008 JunVol. 13 Issue 4
2008 MayVol. 13 Issue 3
2008 AprVol. 13 Supplement 2
ANZSRS and TSANZ Abstracts
2008 MarVol. 13 Supplement 1
ESAP Abstracts
2008 MarVol. 13 Issue 2
2008 JanVol. 13 Issue 1
2007 NovVol. 12 Supplement 4
APSR Congress Abstracts
2007 NovVol. 12 Supplement 3
Asthma
2007 NovVol. 12 Issue 6
2007 SepVol. 12 Issue 5
2007 JulVol. 12 Issue 4
2007 MayVol. 12 Supplement 2
ESAP Abstracts
2007 MayVol. 12 Issue 3
2007 MarVol. 12 Supplement 1
ANZSRS and TSANZ Abstracts
2007 MarVol. 12 Issue 2
2007 JanVol. 12 Issue 1
2006 NovVol. 11 Supplement 5
APSR Congress Abstracts
2006 NovVol. 11 Issue 6
2006 SepVol. 11 Supplement 4
Guidelines: Cough
2006 SepVol. 11 Supplement 3
Guidelines: Respiratory Infections
2006 SepVol. 11 Issue 5
2006 JulVol. 11 Issue 4
2006 MayVol. 11 Issue 3
2006 MarVol. 11 Supplement 2
ANZSRS and TSANZ abstracts
2006 MarVol. 11 Issue 2
2006 JanVol. 11 Supplement 1
Surfactant Molecular Pathophysiology
2006 JanVol. 11 Issue 1
2005 NovVol. 10 Supplement 3
APSR Congress Abstracts
2005 NovVol. 10 Supplement 2
Respiratory function tests
2005 NovVol. 10 Issue 5
2005 SepVol. 10 Issue 4
2005 JunVol. 10 Issue 3
2005 MarVol. 10 Supplement 1
ANZSRS and TSANZ abstracts
2005 MarVol. 10 Issue 2
2005 JanVol. 10 Issue 1
2004 DecVol. 9 Supplement 3
APSR Congress Abstracts
2004 NovVol. 9 Issue 4
2004 AugVol. 9 Issue 3
2004 JunVol. 9 Issue 2
2004 MarVol. 9 Supplement 2
APSR Congress Abstracts
2004 MarVol. 9 Supplement 1
Guidelines: Hospital-Acquired Pneumonia
2004 MarVol. 9 Issue 1
2003 DecVol. 8 Issue 4
2003 NovVol. 8 Supplement 1
SARS
2003 SepVol. 8 Issue 3
2003 JunVol. 8 Issue 2
2003 AprVol. 8 Supplement 2
APSR Congress Abstracts
2003 MarVol. 8 Issue 1
2002 DecVol. 7 Issue 4
2002 SepVol. 7 Issue 3
2002 JunVol. 7 Issue 2
2002 MarVol. 7 Supplement 1
APSR Congress Abstracts
2002 MarVol. 7 Issue 1
2001 DecVol. 6 Issue 4
2001 SepVol. 6 Issue 3
2001 JunVol. 6 Supplement 2
Chronic Obstructive Lung Diseases
2001 JunVol. 6 Issue 2
2001 MarVol. 6 Issue 1
2000 DecVol. 5 Issue 4
2000 SepVol. 5 Issue 3
2000 JunVol. 5 Issue 2
2000 JunVol. 05 Supplement 2
TSANZ abstracts
2000 AprVol. 05 Supplement 1
TSANZ abstracts
2000 MarVol. 5 Issue 1
1999 DecVol. 4 Issue 4
1999 SepVol. 4 Issue 3
1999 JunVol. 4 Issue 2
1999 AprVol. 04 Supplement 1
TSANZ abstracts
1999 JanVol. 4 Issue 1
1998 DecVol. 3 Issue 4
1998 SepVol. 3 Issue 3
1998 JunVol. 3 Issue 2
1998 MarVol. 3 Issue 1
1997 DecVol. 2 Issue 4
1997 SepVol. 2 Issue 3
1997 JunVol. 2 Issue 2
1997 MarVol. 2 Issue 1
1996 DecVol. 1 Issue 4
1996 SepVol. 1 Issue 3
1996 JunVol. 1 Issue 2
1996 MarVol. 1 Issue 1